New cancer drug enters first human trials for Tough-to-Treat tumors
NCT ID NCT06014502
Summary
This is an early-stage study to test the safety and find the right dose of a new investigational drug called IMGS-001. It is for adults with advanced solid tumors that have come back or stopped responding to standard treatments. The study will first test several doses for safety and then look at how the drug might work against specific cancer types.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner MD Anderson Cancer Center
RECRUITINGGilbert, Arizona, 85234, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NEXT Dallas
RECRUITINGIrving, Texas, 75039, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ochsner Clinic Foundation
RECRUITINGNew Orleans, Louisiana, 70121, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarcoma Oncology Center
RECRUITINGSanta Monica, California, 90403, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.